Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News The Latest Analyst Ratings For Boston Scientific is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Demystifying Boston Scientific: Insights From 9 Analyst Reviews
Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target; Steven Lichtman: Oppenheimer: Raises: Outperform: $125.00: $118.00: Danielle Antalffy: UBS: Raise ... Read More
Beyond The Numbers: 6 Analysts Discuss Boston Scientific Stock
In the preceding three months, 6 analysts have released ratings for Boston Scientific (NYSE:BSX), presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments, ... Read More
Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity
Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts. On September 11, analysts at Needham reiterated a ‘Buy’ rating on the stock and a $121 price ... Read More
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) ... Read More
Boston Scientific inks $88M Elutia deal to challenge Medtronic
BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S. cardiac rhythm management sector. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus